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Abstract
Comorbidities of ischemic heart disease, including diabetes mellitus (DM), hypercholesterolemia (HC) and chronic kidney 
disease (CKD), are associated with coronary microvascular dysfunction (CMD). Increasing evidence suggests that CMD may 
contribute to myocardial ‘Ischemia and No Obstructive Coronary Artery disease’ (INOCA). In the present study, we tested the 
hypothesis that CMD results in perturbations in myocardial perfusion and oxygen delivery using a novel swine model with 
multiple comorbidities. DM (streptozotocin), HC (high-fat diet) and CKD (renal embolization) were induced in 10 female 
swine (DM + HC + CKD), while 12 healthy female swine on a normal diet served as controls (Normal). After 5 months, at 
a time when coronary atherosclerosis was still negligible, myocardial perfusion, metabolism, and function were studied at 
rest and during treadmill exercise. DM + HC + CKD animals showed hyperglycemia, hypercholesterolemia, and impaired 
kidney function. During exercise, DM + HC + CKD swine demonstrated perturbations in myocardial blood flow and oxygen 
delivery, necessitating a higher myocardial oxygen extraction—achieved despite reduced capillary density—resulting in 
lower coronary venous oxygen levels. Moreover, myocardial efficiency was lower, requiring higher oxygen consumption for 
a given level of myocardial work. These perturbations in myocardial oxygen balance were associated with lower myocardial 
lactate consumption, stroke volume, and LVdP/dtmax, suggestive of myocardial ischemia and dysfunction. Further analyses 
showed a reduction in adenosine-recruitable coronary flow reserve, but this was exclusively the result of an increase in basal 
coronary blood flow, while maximal coronary flow per gram of myocardium was maintained; the latter was consistent with 
the unchanged arteriolar wall/lumen ratio, arteriolar density and peri-arteriolar collagen content. However, isolated small 
arteries displayed selective blunting of endothelium-dependent vasodilation in response to bradykinin in DM + HC + CKD 
swine, suggesting that changes in coronary microvascular function rather than in structure contributed to the perturbations 
in myocardial oxygen delivery. In conclusion, common comorbidities in swine result in CMD, in the absence of appreciable 
atherosclerosis, which is severe enough to produce perturbations in myocardial oxygen balance, particularly during exercise, 
resembling key features of INOCA.
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Introduction
Common comorbidities of cardiovascular disease, includ-
ing diabetes mellitus (DM), hypercholesterolemia (HC) 
and chronic kidney disease (CKD), are well-known risk 
factors for the development of coronary artery disease of 
both large epicardial arteries and smaller coronary arteries 
[8, 13, 18, 31]. While it is well established that obstruc-
tive coronary artery disease (CAD) is a major cause of 
myocardial ischemia [19], there is increasing evidence that 
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coronary microvascular dysfunction (CMD) also contrib-
utes to myocardial ischemia, not only in the presence of 
obstructive CAD [1, 14, 36, 55] but also in patients without 
obstructive CAD, a situation referred to as ‘Ischemia and 
No Obstructive Coronary Artery disease’ (INOCA) [2, 8, 
36, 44]. Clinical studies have shown that INOCA is present 
in approximately one-third of men and two-thirds of women 
undergoing angiography for suspected ischemic heart dis-
ease and that cardiovascular death or myocardial infarction 
occurred in 6.7% of the patients without any signs of CAD 
and in 12.8% of patients with non-obstructive CAD [32, 53].
Although the mechanisms underlying INOCA remain 
incompletely understood, there is increasing evidence that 
CMD, in particular impaired endothelium-dependent vaso-
dilation, plays an important role [2, 10, 13, 66]. In agreement 
with these clinical observations, experimental data obtained 
in swine chronically exposed to multiple comorbidities, also 
demonstrate endothelial dysfunction of isolated small coro-
nary arteries studied in vitro, in the absence of obstructive 
CAD [54, 57, 63]. However, whether these perturbations 
in coronary microvascular endothelial function translate 
into impaired myocardial perfusion and oxygen delivery 
in vivo, i.e., result in INOCA, was not assessed in these stud-
ies. Consequently, we tested the hypothesis that combined 
comorbidities—as frequently present in patients—result in 
perturbations in myocardial perfusion and oxygen delivery, 
causing a shift towards anaerobic metabolism and cardiac 
dysfunction, particularly during increased myocardial oxy-
gen demand. To test our hypothesis, we studied swine that 
were chronically (5 months) exposed to a combination of 
three common comorbidities—DM + HC + CKD—and that 
have been extensively phenotyped in our previous study [54]. 
Here, swine were chronically instrumented after 5-months 
of exposure to DM + HC + CKD, to allow the assessment of 
systemic and coronary hemodynamics as well as myocardial 
metabolism and function in the awake state, at rest and dur-
ing treadmill exercise.
Materials and methods
Animals
All animal experiments were approved by the Animal Care 
Committee at the Erasmus University Medical Center (Rot-
terdam, The Netherlands) and performed in accordance with 
the “Guiding Principles in the Care and Use of Laboratory 
Animals” as approved by the Council of the American 
Physiological Society. Ten female Yorkshire × Landrace 
swine (25 ± 1 kg) were included in the DM + HC + CKD 
group while 12 healthy female Yorkshire × Landrace swine 
of similar age and weight were used as controls (Normal). 
Two swine assigned to the DM + HC + CKD group died 
prematurely, one animal died 2 weeks after CKD induc-
tion and one animal died during chronic instrumentation 
due to surgical complications. In the Normal group, also 
two swine were lost. One animal died during chronic instru-
mentation, while another animal experienced severe lame-
ness prior to chronic instrumentation and was excluded 
from the study. Four additional swine (two Normal and two 
DM + HC + CKD) were included for measuring coronary 
flow reserve (CFR) in vivo and small artery function ex vivo. 
An overview of the experimental design and technical pro-
cedures is presented in Fig. 1.
Induction of comorbidities
The induction of comorbidities in the DM + HC + CKD 
group has been described in detail elsewhere [54]. Briefly, 
DM was induced by injecting streptozotocin (Bio-Connect 
B.V., Huissen, The Netherlands) at a dose of 50 mg kg−1 
 day−1 i.v. for 3 consecutive days. The severity and stability 
of DM was monitored bi-weekly by measuring blood glu-
cose and ketone levels.
Two weeks after DM induction, animals were sedated 
with intramuscular injection of a cocktail of Zoletil (tile-
tamine/zolazepam; 5  mg  kg−1), Sedazine (xylazine; 
2.25 mg kg−1) and atropine (2 mg) and artificially ventilated 
 (O2 and  N2 [1:2 vol/vol], to which 1–2% (vol/vol) isoflurane 
was added for anesthesia). CKD was produced by micro-
embolization of the global right kidney as well as the lower 
pole of the left kidney. For this purpose, the renal arteries 
were catheterized under fluoroscopy guidance (right renal 
artery and selective catheterization of the artery perfus-
ing the left lower renal pole) with a Swan–Ganz catheter, 
inserted through a 9F sheath in the right common carotid 
artery. Following inflation of the balloon to prevent back-
flow into the aorta, 75 mg of polyethylene microspheres with 
a diameter of 38–42 μm (Cospheric, Santa Barbara, CA, 
USA) were infused into each kidney via the distal port of 
the catheter. The wound was closed and the animals were 
allowed to recover.
One week after CKD induction, a high-fat and high-sugar 
diet containing 10% sucrose, 15% fructose, 25% saturated 
fats and 1% cholesterol (Research Diets Services BV, Wijk 
bij Duurstede, The Netherlands) supplemented with sodium 
chloride (20 g day−1) was gradually introduced. The Nor-
mal group continued to receive regular swine chow. Animals 
were housed in pairs but were fed separately and had ad libi-
tum access to drinking water.
Chronic instrumentation
After an overnight fast, Normal and DM + HC + CKD 
swine (5  months after CKD induction) were sedated 
with an intramuscular injection of a cocktail of Zoletil 
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(tiletamine/zolazepam; 5 mg kg−1), Sedazine (xylazine; 
2.25 mg kg−1) and atropine (2 mg), and artificially venti-
lated  (O2 and  N2 [1:2; vol/vol]), to which 2–2.5% (vol/vol) 
isoflurane was added. As described in detail elsewhere [15], 
a thoracotomy was performed in the fourth left intercostal 
space under sterile conditions and fluid-filled polyvinylchlo-
ride catheters were placed in the left ventricle, aorta, pul-
monary artery, and left atrium for pressure measurements 
and blood sampling. Additionally, flow probes (Transonic 
Systems, Ithaca, NY) were placed around the aorta for 
cardiac output measurement, and around the proximal left 
anterior descending coronary artery to measure coronary 
blood flow. Finally, two small angio-catheters (one as back-
up) were inserted into the anterior inter-ventricular vein 
for coronary venous blood sampling. In one Normal and in 
one DM + HC + CKD animal, the coronary venous angio-
catheters lost patency prior to the exercise study. Electrical 
wires and catheters were tunneled subcutaneously to exit 
through the back of the animal and protected with a vest. 
Then the chest was closed and animals were allowed to 
recover, receiving analgesia (0.3 mg buprenorphine i.m.) 
and a slow-release fentanyl patch (50 μg h−1) for 6 days, 
and antibiotic prophylaxis (25 mg kg−1 amoxicillin i.v.) 
for 7 days. All catheters were flushed daily with heparin-
ized saline (1000–5000 IU ml−1 saline) to prevent the for-
mation of blood clots and maintain catheter patency. One 
DM + HC + CKD swine had a malfunctioning coronary flow 
probe.
In vivo experiments in awake swine
Experiments started 1 week after surgery. First, the glomeru-
lar filtration rate (GFR) was measured at rest, using continu-
ous inulin infusion [54]. On a subsequent day, myocardial 
perfusion and function at rest and during exercise were 
assessed using a motor-driven treadmill exercise protocol. 
Briefly, resting hemodynamic measurements, blood samples, 
and rectal temperature were obtained with swine standing 
quietly on the treadmill. Then swine were subjected to a 
three-stage incremental treadmill exercise protocol (2, 3 and 
4 km h−1 at 0% inclination, 3 min per stage). Hemodynamic 
variables were continuously recorded digitally on a Codas 
workstation (ATCODAS, Dataq Instruments, Akron, OH), 
with blood samples collected during the final 30 s of each 
Fig. 1  Experimental timeline of the DM + HC + CKD swine from 
induction of the comorbidities to the termination. High-fat + high-
sugar +high-salt diet was composed of 10% sucrose, 15% fructose, 
25% saturated fats, and 1% cholesterol supplemented with sodium 
chloride (20 g day−1). Normal swine were weight- and age-matched 
to the DM + HC + CKD swine, were fed normal chow without receiv-
ing the induction of any comorbidities, and underwent chronic instru-
mentation, in vivo experiments and termination according to a simi-
lar protocol as DM + HC + CKD swine. DM diabetes mellitus, CKD 
chronic kidney disease, HC hypercholesterolemia, GFR glomerular 
filtration rate, CFR coronary flow reserve
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exercise stage when steady-state hemodynamics had been 
achieved. Blood samples were analyzed for pO2, pCO2, pH, 
bicarbonate,  O2 saturation  (SaO2), lactate and hemoglobin 
concentration (ABL-800, Radiometer, Copenhagen).
In a seperate experiment,  coronary blood flow was 
measured in awake resting swine (4 Normal and 4 
DM + HC + CKD) under basal conditions and during maxi-
mal coronary vasodilation using intravenous infusion of 
adenosine (0.5 mg kg−1 min−1) in combination with phenyle-
phrine (5–7.5 µg kg−1  min−1) to maintain mean arterial pres-
sure at baseline levels [55]. CFR was calculated as maximal 
coronary blood flow divided by basal coronary blood flow.
Termination
At the termination, swine were sedated by intramuscular 
injection with a cocktail of Zoletil (tiletamine/zolazepam; 
5 mg kg−1), Sedazine (xylazine; 2.25 mg kg−1) and atropine 
(2 mg) and anesthetized with pentobarbital (9 mg kg−1 h−1 
i.v.). Subsequently, a sternotomy was performed and ven-
tricular fibrillation was induced using a 9 V battery, and 
immediately the heart, kidneys, liver and pancreas were 
excised, weighed, prepared, and stored for later biochemi-
cal, molecular, and histological analyses.
In vitro coronary small artery function
In a subgroup of animals (3 Normal and 3 DM + HC + CKD), 
coronary small arteries (∼ 300 µm diameter) were isolated 
from the epicardial surface of the left ventricular apex and 
studied in vitro using a Mulvany wire myograph (DMT, 
Aarhus, Denmark). Vasodilation to the endothelium-
dependent vasodilator bradykinin (BK, 3 × 10−9,  10−8 and 
3 × 10−8  mol  L−1, Sigma–Aldrich, Zwijndrecht, The 
Netherlands) and the nitric oxide donor and endothelium- 
independent vasodilator S-nitroso-N-acetylpenicillamine 
(SNAP,  10−7, 3 × 10−7 and  10−6 mol L−1, Sigma-Aldrich) 
were measured following preconstriction with  10−6 mol L−1 
of the thromboxane-A2 analogue U46619 (Sigma-Aldrich).
Plasma and tissue analyses
Fasting arterial blood samples were obtained at instrumenta-
tion and stored at − 80 °C, for later determination of plasma 
glucose, triglycerides, total cholesterol, low-density lipopro-
tein (LDL), high-density lipoprotein (HDL), aspartate ami-
notransferase (ASAT), alanine aminotransferase (ALAT), 
albumin, sodium, and creatinine, as previously described 
[54]. Arterial plasma concentrations of tumor necrosis fac-
tor alpha (TNF-α, R&D Systems Europe Ltd., Abingdon, 
UK), neutrophil gelatinase-associated lipocalin (Pig NGAL, 
BioPorto Diagnostics A/S, Hellerup, Denmark), and fasting 
insulin (Porcine Insulin, Mercodia AB, Uppsala, Sweden) 
were determined using ELISA kits.
Samples of the pancreas, liver, kidney, left anterior 
descending artery, right coronary artery, left circumflex 
artery, and left ventricular anterior free wall were excised, 
cryo-embedded in Tissue-Tek or fixed in 4% buffered for-
maldehyde, and embedded in paraffin for histological analy-
ses. 4.5-μm-thick slides of the pancreas were stained for 
insulin (FLEX polyclonal anti-insulin, Agilent Technolo-
gies, Santa Clara, CA). Six to eight fields at 200 × magni-
fication were analyzed and data were averaged per animal. 
Cryosections of the liver (4 μm thick) were stained with Oil 
Red O (Sigma-Aldrich) for quantification of liver fat deposi-
tion. Five to seven liver lobes were analyzed and data were 
averaged per animal.
From formaldehyde-fixed, paraffin-embedded kidneys, 
3-μm sections were sliced and stained. For the analysis, the 
upper pole of the left kidney, which was not embolized, was 
used. Tubulo-interstitial damage and glomerulosclerosis 
were scored on periodic acid–Schiff-stained sections in a 
blinded manner. The tubulo-interstitial damage was scored 
in at least 20 different non-overlapping fields per animal 
at a magnification of 200×. The amount of inflammatory 
infiltrate between tubuli, interstitial fibrosis, tubular atrophy, 
and dilatation were scored on a scale of 0–5, with 0 indi-
cating not present, and 5 indicating that > 75% of all tubuli 
were affected. A total tubulo-interstitial damage score was 
calculated by summing the scores for the four variables. Glo-
merular score was performed at a magnification of 400× on 
50 separate glomeruli. The analysis was done by quadrants, 
with the score of 0 indicating that no quadrant was affected 
and 4 indicating that the whole glomerulus was affected. 
Scored variables were matrix expansion, sclerosis, adhesion 
of Bowman’s capsule and dilation, from which a total glo-
merulosclerosis score was then calculated. All renal histo-
logical analyses were performed by observers blinded to the 
treatment of the animal.
Left ventricular anterior wall sections (4.5 μm thick) 
were stained for the quantification of myocardial collagen 
deposition, myocyte size, and capillary density. Six to eight 
fields were examined in the endocardial part of each slide, 
at 200 × magnification. Collagen deposition was assessed 
using Picrosirius red staining, with interstitial and perivas-
cular collagen deposition being analyzed separately. Using 
light microscopy, interstitial collagen was measured as area 
occupied by all collagen fibers and expressed as a percentage 
of the myocardial area, perivascular collagen being excluded 
from this analysis. Using a linear polarization filter, the per-
centage area of the myocardium occupied specifically by 
collagen type I and III fibers was measured [64]. Perivascu-
lar collagen deposition was measured for all coronary arte-
rioles (diameter < 100 µm, excluding capillaries) encoun-
tered in the left ventricular section at 200 × magnification 
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(~ 150 mm2) and expressed as ratio between the perivascular 
area and the lumen diameter. The latter was defined as the 
area encompassed by two times the distance from the lumen 
center to the external elastic lamina in all directions. Cross-
sectional areas of cardiomyocytes with clearly visible nuclei 
were measured for each slide, using a Gomori silver stain. 
Capillary density was quantified using an endothelial cells 
staining with biotin-labeled lectin (lectin 1/100 in 1% bovine 
serum albumin in PBS, Sigma–Aldrich). All vessels smaller 
than 10 μm in diameter and without vascular smooth muscle 
cells were counted. Capillary to fiber ratio was calculated 
by dividing capillary density by the total number of cardio-
myocytes per  mm2.
Right coronary artery, left circumflex artery, left anterior 
descending artery, and left ventricular sections were stained 
with resorcin–fuchsin solution to assess media-to-lumen 
ratios of large coronary arteries and coronary arterioles 
(< 100 µm inner diameter, excluding capillaries). Smooth 
muscle actin was stained (EnVision G|2 doublestain rabbit/
mouse, Agilent Technologies, Santa Clara, CA, USA) in left 
ventricular sections to determine coronary arteriolar densi-
ties, according to an earlier described protocol [65]; in short, 
we counted arterioles of < 100 µm inner diameter with > 2 
smooth muscle layers. All measurements, except for renal 
histological measurements, were performed using a micros-
copy image analysis system (Impak C, Clemex Vision Image 
analysis system, Clemex Technologies, Quebec, Canada).
Data analysis and statistics
Data are presented as mean ± SEM. Digital recording and 
offline analysis of hemodynamic data obtained at rest and 
during exercise was performed. Body  O2 consumption 
(BVO2) was calculated as the product of cardiac output and 
the difference in  O2 content between arterial and mixed 
venous blood. Systemic vascular conductance (SVC) was 
computed as the ratio of cardiac output and mean arterial 
pressure. Myocardial  O2 and lactate delivery were computed 
as the product of coronary blood flow and arterial blood 
 O2 content or arterial lactate concentration. Myocardial  O2 
(MVO2) and lactate consumption were calculated as the 
product of coronary blood flow and the difference in  O2 con-
tent or lactate concentration between arterial and coronary 
venous blood. Myocardial oxygen extraction was computed 
as 100% MVO2/Myocardial O2 delivery. Myocardial work 
was computed as the product of cardiac output and systolic 
arterial pressure. Systemic parameters, including cardiac 
output, BVO2, SVC, cardiac work, and stroke volume, were 
normalized for body weight in kilograms (kg). Myocardial 
parameters including MVO2, coronary blood flow, myo-
cardial oxygen and lactate delivery, and myocardial lactate 
consumption were normalized per gram (g) of myocardium 
perfused by the left anterior descending coronary artery, 
which was estimated to be 40% of the left ventricle [9, 30].
Statistical analysis was performed in SPSS Statistics 21.0 
(IBM Corp, Armonk, NY). Two-way ANOVA for repeated 
measures was used to analyze tabular in vivo hemodynamic 
and myocardial oxygen balance responses to graded tread-
mill exercise, as well as the ex vivo microvascular function, 
with Bonferroni post hoc testing when appropriate. A two-
way ANCOVA was used to analyze hemodynamic and myo-
cardial oxygen balance data expressed as a function of whole 
body—or myocardial—oxygen consumption. Comparison of 
other variables between the two groups was performed by 
unpaired Student’s t test. Correlations were calculated by 
Pearson’s correlation. Statistical significance was accepted 
when p < 0.05 (two tailed).
Results
Model characteristics
Metabolic, renal, inflammatory, and cardiac character-
istics of the DM + HC + CKD swine model at 5-month 
follow-up are presented in Table 1, while representative 
histological sections of pancreas, liver, kidney, left ante-
rior descending coronary artery and left ventricular ante-
rior wall are shown in Fig. 2. Metabolic dysfunction was 
present in DM + HC + CKD swine, with markedly elevated 
levels of plasma glucose, total cholesterol and LDL/HDL 
ratio, and similar triglyceride levels (p = 0.10) as compared 
to healthy Normal swine. Pancreas staining demonstrated 
an ~ 80% reduction of the insulin-producing ß-cells in the 
islets of Langerhans in DM + HC + CKD swine, but insu-
lin plasma levels were maintained. There was no difference 
in ASAT plasma levels between groups, while ALAT lev-
els even decreased in DM + HC + CKD compared to Nor-
mal swine. In addition, DM + HC + CKD showed a trend 
towards an increase in liver fat deposition (p = 0.09), which 
correlated positively with plasma levels of total cholesterol 
(r2 = 0.519, p < 0.05) and correlated inversely with ASAT 
(r2 = 0.466, p < 0.05). Although kidney weights were not 
different from Normal swine, renal dysfunction was present 
in DM + HC + CKD swine reflected in increased creatinine 
plasma levels and a significantly impaired GFR, as measured 
by inulin clearance, increased histological scores of tubulo-
interstitial injury, and glomerular sclerosis. Metabolic and 
renal dysfunction resulted in elevated TNF-α plasma lev-
els. Absolute and relative left ventricular weights were not 
different between groups. Similarly, cardiomyocyte cross-
sectional area showed no significant differences between 
groups. In contrast, total collagen deposition (collagen 
type I and III) was elevated in DM + HC + CKD compared 
to Normal swine. Interestingly, this elevation was due to 
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increased deposition of collagen type I fibers, known to 
form thick and stiff bundles, in DM + HC + CKD compared 
to Normal, while deposition of the compliant thin collagen 
fibers (collagen type III) was unaltered (Supplemental Fig-
ure). Furthermore, significant decreases in left ventricular 
subendocardial capillary density as well as capillary-to-fiber 
Table 1  Metabolic, renal, 
inflammatory and myocardial 
characteristics of Normal and 
DM + HC + CKD swine
Data are mean ± SEM
*p < 0.05 Normal vs DM + HC + CKD
a n number of animals analyzed in the Normal group
b n number of animals analyzed in the DM + HC + CKD group
c GFR obtained in awake animals, 1 week after surgery. Plasma samples were obtained under anesthetized 
basal conditions after onset of surgery
HOMA-IR homeostatic model assessment-insulin resistance, LDL low-density lipoprotein, HDL high- 
density lipoprotein,  ALAT alanine aminotransferase, ASAT aspartate aminotransferase, NGAL neutrophil 
gelatinase-associated lipocalin, BW body weight, TNF-α tumor necrosis factor alpha, CSA cross-sectional 
area, LAD left anterior descending artery, LCX left circumflex artery, RCA right coronary artery
na nb Normal DM + HC + CKD
Body weight (kg) 10 9 93 ± 6 104 ± 6
Metabolic function
 Plasma fasting glucose (mmol  L−1) 10 9 8.4 ± 0.8 19.2 ± 1.5*
 Plasma insulin (µg  L−1) 9 9 0.08 ± 0.03 0.26 ± 0.16
 HOMA-IR 8 9 1.13 ± 0.60 7.36 ± 4.61
 β-Cells of islets of Langerhans (%) 6 7 100 ± 12 17 ± 4*
 Plasma total cholesterol (mmol  L−1) 10 9 1.72 ± 0.08 8.28 ± 0.86*
 LDL/HDL cholesterol ratio 10 9 1.19 ± 0.08 3.51 ± 0.57*
 Plasma triglycerides (mmol  L−1) 10 9 0.20 ± 0.03 0.29 ± 0.05
 Plasma ALAT (U  L−1) 10 9 52 ± 4 24 ± 4*
 Plasma ASAT (U  L−1) 10 9 32 ± 7 23 ± 3
 Liver steatosis (%) 6 7 0.04 ± 0.02 1.41 ± 0.80
Renal function and structure
 Plasma creatinine (µmol  L−1) 10 9 122 ± 4 170 ± 11*
 Glomerular filtration rate (ml min−1)c 7 7 197 ± 10 132 ± 14*
 Plasma sodium (mmol  L−1) 10 9 141 ± 1 134 ± 1*
 Plasma albumin (g  L−1) 10 9 40 ± 1 31 ± 2*
 Plasma NGAL (ng ml−1) 6 9 128 ± 16 164 ± 16
 Right kidney weight (g) 10 9 200 ± 14 184 ± 20
 Left kidney weight (g) 10 9 207 ± 11 177 ± 22
 Right kidney weight/BW (g kg−1) 10 9 1.96 ± 0.15 1.80 ± 0.13
 Left kidney weight/BW (g kg−1) 10 9 2.06 ± 0.13 1.75 ± 0.14
 Tubulo-interstitial injury score 6 5 2.1 ± 0.4 4.3 ± 0.6*
 Glomerular sclerosis score 6 5 18.2 ± 3.0 32.4 ± 3.7*
Inflammation
 TNF-α (pg ml−1) 8 9 25 ± 5 52 ± 5*
Cardiac structure
 Left ventricular weight (g) 10 9 277 ± 12 251 ± 16
 Left ventricular weight/BW (g kg−1) 10 9 2.9 ± 0.2 2.4 ± 0.2
 Cardiomyocyte CSA (µm2) 10 7 582 ± 44 663 ± 110
 Capillary density (#  mm−2) 10 7 1921 ± 157 1381 ± 172*
 Capillary to fiber ratio 10 7 1.33 ± 0.17 0.84 ± 0.09*
 Total collagen (% of myocardium) 10 7 5.7 ± 0.7 9.6 ± 1.9*
Large coronary structure
 LAD media-to-lumen ratio 10 7 0.55 ± 0.05 0.63 ± 0.11
 LCX media-to-lumen ratio 7 6 0.70 ± 0.09 0.57 ± 0.10
 RCA media-to-lumen ratio 9 7 0.72 ± 0.10 0.78 ± 0.10
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ratios were observed in DM + HC + CKD swine. Macro-
scopic and microscopic examination of the large coronary 
arteries, showed no signs of atherosclerosis and no changes 
in media-to-lumen ratio in DM + HC + CKD swine.
Systemic hemodynamics and metabolism
The impact of comorbidities on systemic hemodynamics 
and metabolism was assessed at rest and during graded 
treadmill exercise (Table 2). Although heart rates were 
similar at rest, the exercise-induced increase in heart rate 
was blunted in DM + HC + CKD compared to Normal 
swine, suggestive of chronotropic incompetence. Stroke 
volume was lower in DM + HC + CKD swine at rest 
(Table 2). These alterations in cardiac function resulted 
in a lower cardiac output in DM + HC + CKD compared to 
Normal both at rest and during exercise (Table 2, Fig. 3a). 
Although renal embolization resulted in an acute increase 
in blood pressure, which we previously showed to be sus-
tained for at least 2 months [54], hypertension was no 
longer present at 5 months after renal embolization. The 
normalization of mean aortic blood pressure was likely 
the result of the reduction in cardiac output, as systemic 
vascular conductance was still lower in DM + HC + CKD 
swine (Fig. 3b). The lower cardiac output during exercise 
was only partly compensated for by an increase in body 
oxygen extraction (Fig. 3c). Consequently, the exercise-
induced increase in BVO2 was blunted in DM + HC + CKD 
animals, which was associated with increased circulating 
levels of lactate (Fig. 3d), suggestive of systemic anaer-
obic metabolism and exercise intolerance. Both arte-
rial  pCO2 and bicarbonate levels (arterial  HCO3− at rest 
Fig. 2  Representative histological sections of pancreas, liver, kidney, 
coronary artery, and left ventricle of Normal and DM + HC + CKD 
swine. Representative insulin-stained pancreas sections (a, b) and 
Oil Red O-stained liver sections (c, d) at × 100 magnification, scale 
bar = 250  µm. Periodic acid–Schiff-stained sections of a glomeru-
lus (e, f) at × 400 magnification, scale bar = 40  μm and tubuli (g, 
h) from the top part of the left kidney at × 200 magnification, scale 
bar = 100  µm. Representative resorcin–fuchsin-stained sections of 
the left anterior descending artery (i, j) at × 50 magnification, scale 
bar = 1  mm. Representative sections of the endocardium of the left 
ventricle, lectin stained (k, l), Gomori stained (m, n) and picrosirius 
red stained (o, p) at × 200 magnification, scale bar = 200 µm
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23.6 ± 0.7 vs. 26.7 ± 0.3 mmol L−1 in DM + HC + CKD vs. 
Normal, p = 0.01) were lower in DM + HC + CKD swine at 
rest and during low-intensity exercise, while arterial pH 
was not different between groups (Table 3), suggesting full 
respiratory compensation of metabolic acidosis.
Myocardial oxygen balance, perfusion, 
and metabolism
Compared to normal swine, DM + HC + CKD swine 
required higher levels of MVO2 for each level of cardiac 
Table 2  Systemic 
hemodynamics and 
metabolism of Normal and 
DM + HC + CKD swine at rest 
and during treadmill exercise
Data are mean ± SEM
LVdP/dtmax maximum rate of rise of left ventricular pressure, LVdP/dtmin maximum rate of fall of left ven-
tricular pressure, mLAP mean left atrial pressure, MAP mean arterial pressure, SVC systemic vascular con-
ductance, SaO2 oxygen saturation, BVO2 body oxygen consumption
*p < 0.05 versus rest within group
† p < 0.05 versus corresponding Normal
Rest Exercise (km h−1)
n 2 3 4
Heart rate (beats min−1)
 Normal 10 122 ± 3 184 ± 11* 184 ± 10* 232 ± 8*
 DM + HC + CKD 8 117 ± 4 164 ± 9* 177 ± 11*† 197 ± 12*†
Cardiac output (ml min−1  kg−1)
 Normal 10 127 ± 6 188 ± 7* 195 ± 8* 212 ± 9*
 DM + HC + CKD 8 107 ±  4† 150 ± 7*† 160 ± 7*† 150 ± 22*†
Stroke volume (ml kg−1)
 Normal 10 1.07 ± 0.05 1.04 ± 0.05 0.96 ± 0.06* 0.93 ± 0.05*
 DM + HC + CKD 8 0.92 ± 0.03† 0.92 ± 0.03 0.92 ± 0.03 0.89 ± 0.04
LVdP/dtmax (mmHg s−1)
 Normal 4 3390 ± 230 4660 ± 660 4970 ± 760 5310 ± 700*
 DM + HC + CKD 7 2990 ± 370 3800 ± 490* 4060 ± 610* 4070 ± 630*
LVdP/dtmin (mmHg s−1)
 Normal 4 − 2330 ± 180 − 2740 ± 210 − 3050 ± 250 − 3450 ± 300*
 DM + HC + CKD 7 − 2360 ± 200 − 2770 ± 200* − 2910 ± 220 − 2950 ± 210*
mLAP (mmHg)
 Normal 9 6 ± 1 13 ± 2* 15 ± 1* 18 ± 1*
 DM + HC + CKD 7 5 ± 1 9 ± 1* 11 ± 2*† 13 ± 1*†
MAP (mmHg)
 Normal 10 89 ± 2 95 ± 3* 98 ± 3* 100 ± 3*
 DM + HC + CKD 8 87 ± 2 94 ± 3* 95 ± 4* 96 ± 2*
SVC (ml mmHg −1  min−1  kg−1)
 Normal 10 1.49 ± 0.10 2.02 ± 0.14* 2.04 ± 0.14* 2.16 ± 0.16*
 DM + HC + CKD 8 1.27 ± 0.06 1.64 ± 0.07*† 1.72 ± 0.07* 1.84 ± 0.06*
Hemoglobin (g dL−1)
 Normal 10 9.7 ± 0.4 10.9 ± 0.5* 10.9 ± 0.5* 11.2 ± 0.4*
 DM + HC + CKD 8 9.5 ± 0.4 10.8 ± 0.5* 11.0 ± 0.3* 10.8 ± 0.4*
Arterial  SaO2 (%)
 Normal 10 98 ± 1 98 ± 1 97 ± 1 97 ± 1
 DM + HC + CKD 8 98 ± 1 97 ± 1 98 ± 1 98 ± 1
Mixed venous  SaO2 (%)
 Normal 10 57 ± 2 39 ± 2* 35 ± 3* 29 ± 2*
 DM + HC + CKD 8 50 ±  1† 34 ± 1* 33 ± 2* 28 ± 2*
BVO2 (mmol min−1  kg−1)
 Normal 10 0.33 ± 0.03 0.77 ± 0.05* 0.84 ± 0.07* 1.01 ± 0.05*
 DM + HC + CKD 8 0.31 ± 0.02 0.66 ± 0.05* 0.73 ± 0.07* 0.80 ± 0.06*†
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work, particularly during exercise, reflecting decreased 
myocardial efficiency (Fig. 4a). The higher levels of MVO2 
in DM + HC + CKD swine were not fully met by com-
mensurate increases in coronary blood flow (Fig. 4b) and 
myocardial  O2 delivery (Fig. 4c), necessitating an increase 
in myocardial oxygen extraction (Fig. 4d), that resulted in 
reductions in coronary venous pO2 (Fig. 4e) and coronary 
venous  SaO2 (Fig. 4f) in DM + HC + CKD compared to 
Normal swine, both at rest and during exercise. Consistent 
with the impaired myocardial  O2 delivery during exercise, 
a decrease in myocardial lactate extraction for a given level 
of myocardial oxygen consumption (Fig. 4g) or myocardial 
lactate consumption for a given level of myocardial lactate 
delivery (Fig. 4h) was observed in DM + HC + CKD swine 
compared to Normal, suggestive of anaerobic metabolism.
Coronary flow reserve, structure, and endothelial 
function
Consistent with an impaired recruitment of vasodilator 
reserve during exercise in DM + HC + CKD, CFR was 
reduced by 25% from 3.64 ± 0.24 in Normal to 2.69 ± 0.27 
in DM + HC + CKD swine (p = 0.038), which appeared to 
be principally due to a small increase in basal flow while 
maximal flow was unaltered (Fig. 5). The latter was con-
sistent with the lack of alterations in morphology or density 
of left ventricular small arterioles, evidenced by similar 
perivascular collagen content (Fig. 6a–c), media-to-lumen 
ratios (Fig. 6d–f) and arteriolar densities (Fig. 6g–i) between 
groups. Interestingly, coronary microvascular function 
measurements in vitro confirmed coronary microvascular 
endothelial dysfunction as vasodilation to bradykinin was 
blunted in DM + HC + CKD compared to Normal (Fig. 7a), 
while vascular smooth muscle cell function was maintained 
(Fig. 7b).
Left ventricular function
The perturbations in myocardial oxygen balance in 
DM + HC + CKD swine were associated with a lower stroke 
volume, both at rest and during exercise (Fig. 8a), as well as 
a trend towards a lower LVdP/dtmax during exercise (Fig. 8b). 
No differences were observed in LVdP/dtmin (Fig. 8c) or left 
atrial pressure (Fig. 8d), either at rest or during exercise, 
between the two groups.
Discussion
The present study tested the hypothesis that prolonged expo-
sure to comorbidities results in perturbations in myocardial 
blood flow and oxygen delivery, leading to a shift towards 
anaerobic metabolism and cardiac dysfunction in exercising 
swine. The main findings were that (i) the combination of 
diabetes mellitus, hypercholesterolemia and chronic kidney 
disease resulted in lower cardiac output at rest and during 
exercise, which was accompanied by impaired systemic 
vasodilatation and increased circulating levels of lactate. 
(ii) Exposure to these comorbidities resulted in increased 
levels of oxygen consumption at similar levels of cardiac 
work, indicating reduced myocardial efficiency. (iii) The 
comorbidities also resulted in perturbations in myocardial 
perfusion and oxygen delivery, at a time when coronary 
atherosclerosis was negligible. (iv) The perturbations in 
myocardial oxygen balance were associated with lower 
lactate consumption and reductions in stroke volume and 
LVdP/dtmax, suggestive of myocardial ischemia and dys-
function. (v) Adenosine-recruitable coronary flow reserve 
was reduced, which was due to an increase in basal resting 
coronary blood flow per gram of myocardium. In contrast, 
maximal coronary blood flow per gram of myocardium was 
not altered, consistent with maintained arteriolar densities 
Fig. 3  Systemic exercise response in DM + HC + CKD and Normal 
swine. DM + HC + CKD swine show a lower cardiac output (a), a 
lower systemic vascular conductance (SVC b), a higher body oxygen 
 (O2) extraction (c), and higher arterial lactate levels (d) for the same 
level of body oxygen consumption as compared to Normal. Data are 
mean ± SEM. DM + HC + CKD n = 8 and Normal n = 10. *p < 0.05 
DM + HC + CKD versus Normal by repeated measures two-way 
ANCOVA
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and wall/lumen ratios and maintained perivascular collagen 
content. (vi) Coronary small arteries demonstrated selec-
tive blunting of endothelium-dependent vasodilation. The 
implications of these findings will be discussed.
Coronary microvascular dysfunction
The presence of risk factors, including DM, HC and CKD, 
has been associated with CMD and INOCA in both experi-
mental [5, 57, 63] and clinical [2, 41, 42, 44] studies. For 
example, we previously showed that CMD was already pre-
sent in swine 2.5 months after the induction of DM and 
HC in the absence of coronary atherosclerosis [63]. Further-
more, CMD remained present in swine with 15-month dia-
betes and hypercholesterolemia with modest non-obstructive 
atherosclerosis [57], and was also found in a swine model of 
familial hypercholesterolemia (FH) with moderate (20–60%) 
coronary plaque burden [5]. Here, we observed coronary 
microvascular endothelial dysfunction in isolated small 
arteries studied ex vivo, in the absence of atherosclerosis 
Table 3  Myocardial metabolism 
of DM + HC + CKD and 
Normal swine at rest and during 
treadmill exercise
Data are mean ± SEM
SaO2 oxygen saturation, pO2 partial pressure of oxygen, pCO2 partial pressure of carbon dioxide, MVO2 
myocardial oxygen consumption per gram of myocardium
*p < 0.05 versus rest within group
† p < 0.05 versus corresponding Normal
Rest Exercise (km h−1)
n 2 3 4
Arterial  SaO2 (%)
 Normal 9 98 ± 1 98 ± 1 97 ± 1 97 ± 1
 DM + HC + CKD 8 98 ± 1 97 ± 1 99 ± 1 98 ± 1
Coronary venous  SaO2 (%)
 Normal 9 22 ± 1 23 ± 1 20 ± 1 20 ± 2
 DM + HC + CKD 8 17 ±  1† 16 ±  1† 16 ± 1 15 ±  1†
Arterial pO2 (mmHg)
 Normal 9 109 ± 4 102 ± 5* 101 ± 5* 99 ± 4*
 DM + HC + CKD 8 110 ± 3 101 ± 3* 108 ± 5 107 ± 5
Coronary venous pO2 (mmHg)
 Normal 9 24 ± 1 25 ± 1 24 ± 1 24 ± 1
 DM + HC + CKD 8 20 ±  1† 21 ±  1† 21 ±  1† 20 ±  1†
Arterial lactate (mmol L−1)
 Normal 9 0.76 ± 0.08 1.12 ± 0.12* 1.89 ± 0.45* 2.83 ± 0.70*
 DM + HC + CKD 8 1.84 ± 0.50† 2.56 ± 0.74 2.93 ± 0.88 3.85 ± 1.39
Coronary venous lactate (mmol L−1)
 Normal 9 0.36 ± 0.04 0.81 ± 0.23 1.19 ± 0.32 1.95 ± 0.54*
 DM + HC + CKD 8 1.76 ± 0.49† 1.98 ± 0.63 2.65 ± 0.96 3.28 ± 1.44
Arterial pH
 Normal 9 7.44 ± 0.01 7.46 ± 0.01* 7.46 ± 0.01* 7.46 ± 0.01*
 DM + HC + CKD 8 7.43 ± 0.01 7.46 ± 0.01* 7.47 ± 0.01* 7.47 ± 0.01*
Coronary venous pH
 Normal 9 7.36 ± 0.01 7.35 ± 0.01 7.35 ± 0.01 7.33 ± 0.01
 DM + HC + CKD 8 7.36 ± 0.01 7.38 ± 0.01 7.38 ± 0.02† 7.36 ± 0.02
Arterial pCO2 (mmHg)
 Normal 9 39 ± 1 37 ± 1* 36 ± 1* 35 ± 1*
 DM + HC + CKD 8 36 ±  1† 34 ±  1† 31 ± 1*† 30 ± 1*†
Coronary venous pCO2 (mmHg)
 Normal 9 51 ± 1 50 ± 2 50 ± 2 48 ± 2
 DM + HC + CKD 8 46 ±  1† 44 ±  1† 42 ± 1*† 44 ± 2*
MVO2 (µmol min−1 g−1)
 Normal 9 5.6 ± 0.4 8.5 ± 0.5* 9.5 ± 0.5* 11.1 ± 0.7*
 DM + HC + CKD 7 6.5 ± 0.9 10.5 ± 1.6* 11.5 ± 1.6* 12.6 ± 1.8*
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which is in line with our previous study [54]. Taken together, 
these studies indicate that CMD is present well before coro-
nary atherosclerosis occurs and remains present once the 
process of atherosclerosis advances.
The present study in chronically instrumented swine 
demonstrates that comorbidities can cause significant per-
turbations in myocardial oxygen balance both at rest and 
particularly during exercise. Thus, DM + HC + CKD ani-
mals demonstrated increased myocardial oxygen consump-
tion at a given level of cardiac work, particularly during 
exercise, causing a counterclockwise rotation in the relation 
between cardiac work and oxygen consumption (Fig. 4a). 
This reduced myocardial efficiency in DM + HC + CKD is 
commonly seen in metabolic disorders, including diabetes 
and dyslipidemia [5, 7, 23]. The mechanisms underlying 
the observed myocardial inefficiency in DM + HC + CKD 
swine were not investigated in the present study, but could be 
several-fold. First, a myocardial substrate shift towards free 
fatty acid utilization leading to a reduced phosphate/oxygen 
ratio could have contributed to the increased oxygen con-
sumption [7, 11, 26]. Second, and more likely, mitochondrial 
uncoupling [7, 11, 23, 52], possibly due to oxidative stress 
[7], could also lead to a decrease in phosphate/oxygen ratio, 
thereby increasing oxygen consumption at a given level of 
cardiac work.
Although mitochondrial function was not measured in the 
present study, a direct link between cardiac mitochondrial 
Fig. 4  Myocardial blood flow and oxygen balance in 
DM + HC + CKD and Normal swine at rest and during graded 
treadmill exercise. Myocardium of DM + HC + CKD swine shows 
increased oxygen consumption for the same level of cardiac work 
(a), a trend towards impaired coronary blood flow especially dur-
ing exercise (b), have a lower myocardial oxygen delivery (c), and a 
higher oxygen extraction (d), which results in lower coronary venous 
oxygen pressure (cvPO2 e) and coronary venous oxygen satura-
tion  (cvSaO2 f). Lower myocardial lactate extraction (g) and lower 
myocardial lactate consumption for a given level of myocardial lac-
tate delivery (h) were measured in DM + HC + CKD as compared to 
Normal animals. Data are mean ± SEM. DM + HC + CKD: n = 7–8, 
Normal: n = 9. *p < 0.05 DM + HC + CKD versus Normal, (*)p < 0.1 
DM + HC + CKD versus Normal by repeated measures two-way 
ANCOVA
Fig. 5  Coronary blood flow during baseline conditions and during 
maximal vasodilation to adenosine (a) resulting in a decrease in coro-
nary flow reserve in DM + HC + CKD (b) compared to Normal swine 
at rest and awake state. Data are mean ± SEM. DM + HC + CKD: 
n = 4, Normal: n = 4. *p < 0.05 DM + HC + CKD versus Normal by 
unpaired t test
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Fig. 6  Typical examples of small arterioles (< 100 µm) stained with 
picrosirius red staining of Normal (a) and DM + HC + CKD (b) and 
perivascular fibrosis quantification as area collagen corrected for 
lumen diameter (c). Typical examples of small arterioles (< 100 µm) 
stained with resorcin–fuchsin of Normal (d) and DM + HC + CKD (e) 
and media thickness corrected for lumen diameter (f). Typical exam-
ples of small arterioles stained for smooth muscle actin of Normal (g) 
and DM + HC + CKD (h) and quantification of coronary arteriolar 
density (<  100  µm, i). Normal n = 10, DM + HC + CKD n = 7. Data 
are mean ± SEM
Fig. 7  Ex vivo endothelium-dependent and endothelium-independ-
ent vasoreactivity of coronary microvessels. Small coronary arter-
ies (~ 300 µm) of DM + HC + CKD have impaired bradykinin (BK)-
induced vasodilation, suggesting endothelial dysfunction (a), while 
endothelium-independent vasodilation to nitric oxide donor sodium 
nitroprusside (SNAP) was unaltered, indicating maintained vascular 
smooth muscle cell function (b). Normal n = 3 and DM + HC + CKD 
n = 3. Data are mean ± SEM. Error bars are presented but might be 
too small to be visible. *p < 0.05 DM + HC + CKD versus Normal by 
repeated measures two-way ANOVA
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dysfunction and microvascular dysfunction in animal mod-
els of metabolic disease was recently proposed [5, 23]. In 
accordance with this concept, we observed a reduction in 
CFR of approximately 25% in DM + HC + CKD swine, as 
compared to Normal swine, which was principally due to 
an increase in basal coronary blood flow as a result of an 
increase in myocardial oxygen consumption. Strikingly, 
maximal myocardial blood flow was maintained, which was 
in accordance with the normal arteriolar morphology and 
density, and unaltered peri-arteriolar collagen content. Our 
finding of a reduction in CFR due to an increase in basal 
coronary flow, rather than a decrease in maximal flow, is also 
in good agreement with observations in a variety of patient 
groups. Thus, in INOCA patients with functional CMD [50], 
in patients with residual CMD after undergoing percutane-
ous coronary intervention for obstructive CAD [27], and in 
patients with diabetes mellitus [46], an increase in basal cor-
onary blood flow per gram of myocardium [50] or increases 
in basal coronary flow velocity [27, 46], as compared to 
healthy individuals, appears primarily responsible for the 
reduction in CFR. Moreover, patients with a reduced CFR 
and an increased basal blood flow demonstrate an increased 
cardiovascular mortality risk compared to patients with nor-
mal basal coronary blood flow and CFR [24]. Also, among 
patients with diabetes, women had a lower CFR than men 
due to higher basal myocardial blood flow [25]. Interest-
ingly, the increase in basal myocardial blood flow correlated 
with diastolic dysfunction in women, but not in men, while 
CFR did not correlate with diastolic dysfunction in either 
sex [25]. In light of these observations, it was recently pro-
posed that basal myocardial blood flow could represent a 
potentially superior marker of CMD in certain pathological 
settings [4].
The present study further shows that the basal higher 
oxygen consumption in DM + HC + CKD was not fully met 
by a commensurate increase in myocardial oxygen deliv-
ery, which necessitated an increase in myocardial oxygen 
extraction, resulting in lower levels of coronary venous oxy-
gen content. Cardiovascular comorbidities can cause per-
turbations in myocardial oxygen delivery by affecting the 
coronary circulation at different levels, including proximal 
obstructive CAD, distal small artery and arteriolar dys-
function and remodeling, and alterations in capillary struc-
ture and function [43]. In the present study, the increase 
in oxygen extraction occurred in the absence of coronary 
atherosclerosis and despite a reduction in capillary den-
sity, which acts to reduce oxygen extraction capacity [43]. 
Moreover, coronary microvascular structure and maximal 
coronary blood flow per gram of myocardium were main-
tained. Hence, the increased oxygen extraction most likely 
reflects perturbations in the regulation of resistance vessel 
tone—likely involving endothelial dysfunction—resulting in 
impaired myocardial blood flow and oxygen delivery in the 
face of increased oxygen consumption [17, 43].
The perturbations in myocardial oxygen delivery were 
accompanied by a reduction in lactate consumption—par-
ticularly during exercise—indicating a shift towards anaer-
obic metabolism, suggestive of myocardial ischemia [28]. 
Although the reduction in lactate consumption may, in part, 
be caused by a DM-induced reduction in pyruvate dehydro-
genase activity [22], in three out of eight DM + HC + CKD 
swine, we observed net lactate production under resting con-
ditions, which can only be explained by anaerobic metabo-
lism [28]. Our observations are consistent with the concept 
that CMD, in the absence of coronary atherosclerosis, can 
impair myocardial oxygenation severely enough to produce 
myocardial ischemia [13, 32, 44, 47, 53, 59]. Furthermore, 
Fig. 8  Left ventricular function in DM + HC + CKD and Normal 
swine at rest and during graded treadmill exercise. DM + HC + CKD 
swine have a lower stroke volume (a), a trend towards an impaired 
left ventricular systolic function (LVdP/dtmax, b), similar left ven-
tricular diastolic function (LVdP/dtmin, c) for the identical body oxy-
gen consumption levels, and similar mean left atrial pressures for 
the same level of cardiac output (d) compared to Normal. Stroke 
volume, mean left atrial pressure and cardiac output measurements: 
DM + HC + CKD n = 8 and Normal n = 10; LVdP/dtmax and LVdP/
dtmin: DM + HC + CKD n = 7 Normal n = 4. Data are mean ± SEM. 
*p < 0.05 DM + HC + CKD versus Normal, (*)p = 0.053 
DM + HC + CKD versus Normal by repeated measures two-way 
ANCOVA
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these findings are in agreement with accumulating clinical 
evidence that myocardial ischemia can also occur in the 
absence of obstructive CAD, termed INOCA [2, 40, 44, 47, 
59], indicating that swine with DM + HC + CKD represent 
a bona fide large animal model of INOCA.
Coronary microvascular dysfunction and diastolic 
dysfunction
There is increasing evidence that comorbidities such as DM, 
dyslipidemia and CKD are linked not only to INOCA [2, 
8, 13] but also to the development of diastolic dysfunction 
and heart failure with preserved ejection fraction (HFpEF), 
involving endothelial dysfunction [45]. It has thus been pro-
posed that INOCA and HFpEF both originate from CMD 
but that the paracrine effect of endothelial dysfunction is 
exerted on distinctive cell types, i.e., arteriolar vascular 
smooth muscle cells in INOCA versus cardiomyocytes in 
HFpEF, respectively [12]. Although we did not observe per-
turbations in active left ventricular relaxation, as evidenced 
by the maintained relation between LVdP/dtmin and body 
 O2 consumption, we observed in our previous study (using 
the same animal model), an increase in left ventricular pas-
sive stiffness evidenced by an increase in the slope of the 
end-diastolic pressure volume relation, in the presence of a 
maintained ejection fraction [54]. The present study in the 
same animal model shows that not only capillary rarefaction 
but also impaired regulation of myocardial perfusion by the 
coronary resistance vessels occurs, which is associated with 
endothelial dysfunction. These experimental findings are in 
agreement with recent clinical studies, demonstrating the 
coexistence of diastolic dysfunction or HFpEF and micro-
vascular angina [12, 41, 60]. Reduced coronary or myocar-
dial flow reserve, independent of coronary artery stenosis, is 
considered to be a marker of microvascular endothelial dys-
function and is present in patients with HFpEF or diastolic 
dysfunction [16, 58, 60]. Thus, the common denominator 
linking HFpEF and INOCA appears to be CMD induced by 
comorbidities [20, 39, 45].
Our DM + HC + CKD swine model represents a model 
of early diastolic dysfunction (or pre-HFpEF), as left atrial 
pressures were not elevated either at rest or during exercise. 
Nevertheless, cardiac output was decreased which was due 
to a decrease in stroke volume as well as to chronotropic 
incompetence, i.e., limited capacity of the DM + HC + CKD 
swine to increase their heart rate during exercise. The lat-
ter is a common feature seen in HFpEF patients with CKD 
[34], as well as diabetic patients [33]. Chronotropic incom-
petence is thought to be the result of downregulation and/or 
desensitization of myocardial β-adrenergic receptors due to 
increased levels of catecholamines [6]. Although the HFpEF 
phenotype was still mild, advanced CMD was already pre-
sent, indicating that CMD may precede advanced diastolic 
dysfunction and HFpEF. This was also suggested by a recent 
clinical study showing that in patients with a reduced CFR, 
diastolic function worsens progressively over time and is 
associated with an increased risk of HFpEF hospitalization 
[60]. Taken together, these findings are consistent with the 
concept of CMD being the primary defect that subsequently 
leads to diastolic dysfunction, eventually progressing to 
overt HFpEF.
Methodological considerations
Although several large and small animal models (for CMD) 
have been described, no single animal model perfectly emu-
lates the human disease [56]. In the present study, CMD was 
induced by prolonged exposure to diabetes, high-fat diet and 
CKD, comorbidities commonly observed in patients with 
INOCA [2]. A type 2-like DM phenotype, with significant 
hyperglycemia, was induced using multiple low-dose strep-
tozotocin injections combined with a high-fat and high-fruc-
tose diet, as previously described [21, 48, 54, 56, 57, 63]. 
Although disease development differs from the slow-onset 
of DM type 2 in humans, this approach produces sustained 
hyperglycemia without insulin dependency and results in 
progressive insulin resistance [54, 57, 63]. Moreover, in 
conjunction with the high-fat and high-fructose diet, this 
experimental approach results in dyslipidemia [54, 56, 57, 
63], thereby mimicking several features of metabolic dys-
regulation as observed in the clinical setting.
It is increasingly recognized that CKD is an important 
risk factor for the development of CMD [3, 49]. The exact 
mechanisms of the detrimental effects of CKD on coronary 
microvascular function are incompletely understood, but 
low-grade inflammation and increased circulation of uremic 
toxins are proposed to play a role [62]. In humans, CKD is 
often the result of local renal inflammation, hypoxia, and 
loss of glomeruli and tubuli, with subsequent hyperfiltra-
tion of healthy regions, resulting in a vicious cycle of pro-
gressive kidney damage [61]. Animal models of renovascu-
lar hypertension, 5/6 nephrectomy, and unilateral ureteric 
obstruction have been used by other investigators to mimic 
various aspects of CKD [35, 51]. Here, partial renal micro-
embolization with microspheres was used to induce CKD. 
This method results in glomerulosclerosis and tubulointer-
stitial damage not only in the embolized areas, but also in 
the remodeled, non-embolized upper pole of the left kid-
ney [54]. These key features of human CKD resulted in a 
reduced GFR, measured by gold-standard inulin clearance, 
and increased creatinine levels. The combination of DM, 
HC, and CKD resulted in a phenotype resembling INOCA 
in humans. However, the specific contribution of the indi-
vidual factors and their potential synergistic action remains 
to be established.
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The present study further demonstrates that functional 
changes in the coronary microvasculature are already pre-
sent well before overt plaque formation occurs. These early 
changes result in an impaired myocardial oxygen balance 
and reduced cardiac efficiency. The observation in a small 
group of animals that endothelial function in isolated coro-
nary small arteries was perturbed, suggests a role for the loss 
of nitric oxide in mediating the impairments in myocardial 
oxygenation in DM + HC + CKD animals. Future studies 
should focus in more detail on the mechanisms underlying 
the increased myocardial oxygen consumption as well as the 
perturbations in oxygen delivery.
Although our data provide valuable information regard-
ing the mechanisms of CMD at this early stage, without the 
influence of proximal obstructive CAD possibly affecting 
the distal microvasculature [55], it is increasingly recognized 
that there may be an interaction between non-obstructive 
and obstructive CAD. Thus, CMD may induce a decrease 
in shear stress in the large vessels and aggravate proximal 
CAD, whereas proximal CAD may further induce CMD, 
potentially mediated by multiple processes involving micro-
embolization and the release of vasoconstrictors [29, 37, 55]. 
Investigation of such interaction of obstructive CAD with 
CMD, by combining a chronic proximal coronary artery 
stenosis [37, 55] with the current model of comorbidities-
induced CMD, should be the topic of future studies. Such 
studies should then also include the assessment of flow dis-
tribution across the left ventricular wall, as the presence of a 
coronary artery stenosis causes a regional flow redistribution 
away from the subendocardium towards the subepicardium 
[17], whereas comorbidities in the absence of obstructive 
CAD appear to result in more diffuse and transmurally 
homogeneous reductions in myocardial blood flow [5, 38, 
50].
Conclusion
The present study is the first to investigate the effects of 
three common risk factors on myocardial oxygen balance in 
swine at rest and during graded treadmill exercise. Our find-
ings demonstrate that, in the absence of coronary atheroscle-
rosis, comorbidities can result in CMD that is severe enough 
to critically impair myocardial oxygenation, thereby result-
ing in anaerobic metabolism. Thus, our DM + HC + CKD 
swine model represents a bona fide large animal model of 
INOCA. A link between CMD and left ventricular diastolic 
dysfunction has recently been shown in clinical studies. 
In our model, overt CMD is present at a time when dias-
tolic dysfunction is still modest [54]. These findings are in 
agreement with clinical observations [12, 41, 60] and sup-
port the concept that CMD is one of the drivers of diastolic 
dysfunction in patients with comorbidities, suggesting that 
CMD represents a prime target for therapeutic interventions 
in INOCA as well as diastolic dysfunction/HFpEF.
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